PTEN and central nervous system cancer: In most tumors the loss of PTEN is monoallelic (gliomas, breast, colon, lung), with biallelic being less frequent [24–27], as inactivation due to methylation of promoter areas is one of the inactivation mechanisms that occurs more frequently than genomic alterations [24, 28, 29].